Nicassist Minty Fresh (Nicotine)

Nicotine, the active ingredient in Nicassist Minty Fresh, is a nicotine replacement therapy presented as an oromucosal product for use in adults seeking to quit smoking. It helps alleviate nicotine withdrawal symptoms and supports gradual reduction of nicotine dependence.

GNH USA supplies Nicassist Minty Fresh as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicassist Minty Fresh is a nicotine replacement therapy used within the smoking cessation pathway.

Smoking cessation: assists adults in reducing cravings and withdrawal symptoms while quitting tobacco use. Nicotine dependence: provides a controlled nicotine source to facilitate gradual tapering of nicotine intake.

Adverse reactions may occur with oromucosal nicotine products. Patients should be aware of both common and less frequent events.

Common Side Effects: - Mouth irritation or soreness - Throat discomfort - Nausea or upset stomach - Hiccups - Dizziness or light‑headedness - Headache

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, difficulty breathing) - Cardiovascular events (palpitations, hypertension, arrhythmia) - Severe hypotension - Seizures (rare)

Before using Nicassist Minty Fresh, consider the following safety measures.

Cardiovascular assessment: evaluate patients with uncontrolled hypertension or recent heart disease. Pregnancy and lactation: use only if benefits outweigh potential risks; consult a healthcare professional. Concurrent nicotine products: avoid using multiple nicotine sources simultaneously. Children safety: keep out of reach of children and pets. Medication review: discuss all current medicines with a prescriber. Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Nicotine may interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid): - CYP2A6 inhibitors (e.g., methoxsalen): may increase nicotine plasma levels. - Insulin or oral hypoglycemics: nicotine can affect glucose control, requiring dose adjustments.

Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine‑induced tachycardia may be masked. - MAO inhibitors: increased risk of hypertension. - Antidepressants (SSRIs, SNRIs): monitor for altered blood pressure. - Anticoagulants (warfarin): nicotine may affect clotting parameters.